RESEARCH MONOGRAPH · KDC-MN-398

L-Glutamine

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

72/100

Important amino acid that's largely useless as an oral supplement except in specific clinical contexts

L-glutamine is fascinating as biology and mostly disappointing as a supplement. It's the most abundant free amino acid in plasma and muscle, a primary fuel for enterocytes and rapidly dividing immune cells, a nitrogen carrier between tissues, and the substrate for both glutamate and GABA neurotransmitter synthesis through different pathways. Every textbook chapter on amino acid metabolism leans on glutamine.

The supplement positioning is the problem. Glutamine became popular in the 1990s on the back of two real findings: critical care patients with severe gut injury or sepsis show clinical benefit from parenteral glutamine, and sickle cell patients show meaningful reduction in pain crises with chronic high-dose oral glutamine (which is the FDA-approved Endari indication, 30 g/day). Both are real. Neither generalizes to healthy populations using 5 to 10 g of glutamine post-workout, which is what the bodybuilding market does.

The healthy-population trial data is mostly null. Glutamine doesn't meaningfully improve recovery, body composition, or immune function in well-fed athletes at the doses they typically take. The biology is sound (glutamine demand goes up during heavy training, enterocyte glutamine consumption increases) but the supplementation doesn't move the needle measurably in healthy adults because endogenous synthesis from BCAAs and other precursors keeps plasma glutamine in range.

What we like as a research tool: glutamine is a useful tool compound in cell culture (where it's a major nitrogen source for proliferating cells, hence its presence in basically every media formulation), in critical care research, and in gut barrier work where enterocyte glutamine availability is rate-limiting.

What we don't like is the bodybuilding marketing context. The post-workout glutamine product category is one of the clearest examples of a real biological story being overextended into a supplement use case where the evidence doesn't support it.

Sourcing is trivial. L-glutamine is one of the cheapest amino acids. The catch is solution stability, glutamine is unstable in aqueous solution at neutral pH and degrades to pyroglutamate and ammonia over time, which is why cell culture media is usually supplemented with alanyl-glutamine dipeptide instead of free glutamine.

Evidence: 55
Mechanism: 85
Reliability: 55
Safety: 92
Sourcing: 92
Value: 80
Signal: 50
Staying power: 70

Plain-language summary Intrigue 38 / 100

L-glutamine is the most abundant free amino acid in human plasma, serving as a fuel substrate for gut lining cells and immune cells and as an ammonia transport carrier. Clinical evidence is solid in critical illness contexts (severe burns, sepsis, post-surgical recovery), where parenteral or enteral glutamine improves nitrogen balance and may reduce infection rates. The popular supplement use in healthy athletes for recovery and immune support, however, has very thin supporting evidence: most oral glutamine is extracted by the gut on first pass and never reaches systemic circulation. Reference amino acid in immunometabolism and clinical nutrition research, but generally overhyped in the supplement context. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Conditionally essential amino acid (immunometabolic substrate)

L-glutamine; the most abundant free amino acid in plasma; a substrate for enterocyte and immune cell metabolism and a popular but evidence-limited supplement.

Abstract

L-glutamine ((S)-2,5-diamino-5-oxopentanoic acid; CAS 56-85-9; molecular formula C5H10N2O3; molecular weight 146.14) is a conditionally essential alpha-amino acid that is the most abundant free amino acid in human plasma (approximately 500 to 800 micromolar). Glutamine is biosynthesized from glutamate and ammonia by glutamine synthetase, with skeletal muscle and lung as principal source tissues. The compound serves as a substrate for enterocyte and immune cell metabolism (the principal biological role outside protein synthesis) and as an ammonia transport carrier. Clinical use is well-established in critical illness (burn injury, sepsis, post-surgery) where parenteral or enteral glutamine improves nitrogen balance and may reduce infection rates; the supplement use in healthy athletes for recovery and immune support has limited supporting evidence. Plasma half-life is approximately 1 hour; the gut largely extracts oral glutamine, with minimal systemic delivery. Used as a reference amino acid in immunometabolism and clinical nutrition research.

Mechanism of action

Conditionally essential amino acid; substrate for enterocyte and immune cell metabolism; ammonia transport carrier.

Reported research dose ranges

Reported research dose ranges vary across the published literature.

References

Wernerman J. Glutamine and intensive care unit patients. JPEN J Parenter Enteral Nutr 2008.
Gleeson M. Dosing and efficacy of glutamine supplementation in human exercise and sport training. J Nutr 2008.
Wischmeyer PE. Glutamine: mode of action in critical illness. Crit Care Med 2007.

Read the full monograph

Available as a research-use-only PDF download.

KDC-MN-398

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

L-Glutamine

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs